• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4635029)   Today's Articles (23)   Subscriber (50019)
For: Papp K, Bissonnette R, Ohtsuki M, Ferris L, Paul C, Lebwohl M, Leonardi C, Braun D, Zhao F, Reich K. 059 Ixekizumab shows no association with MACE in patients with moderate-to-severe psoriasis: an integrated safety analysis of clinical trials. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.06.076] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Number Cited by Other Article(s)
1
Azevedo A, Torres T. Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis. ACTAS DERMO-SIFILIOGRAFICAS 2017. [DOI: 10.1016/j.adengl.2016.09.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
2
Azevedo A, Torres T. Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis. ACTAS DERMO-SIFILIOGRAFICAS 2017;108:305-314. [DOI: 10.1016/j.ad.2016.09.021] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2016] [Revised: 09/14/2016] [Accepted: 09/18/2016] [Indexed: 01/18/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA